An Application of Dang Gui Bu Xue Tang
Danggui Buxue Tang (DBT), a herbal decoction containing
Astragali Radix (AR) and Angelicae Sinensis Radix (ASR), has been used in
treating menopausal irregularity in women for more than 800 years in China.
Pharmacological results showed that DBT exhibited significant estrogenic
properties in vitro, which therefore suggested that DBT could activate the
nuclear estrogen receptors. Here, we assessed the estrogenic properties of DBT
in an ovariectomized in vivo rat model: DBT was applied to the ovariectomized
rats for 3 days. The application of DBT did not alter the weight of uterus and
liver, as well as the transcript expression of the proliferation markers
including the estrogen receptors α and β. However, DBT stimulated the
transcript expression of the estrogen responsive genes. In addition, the
inductive role of DBT on the expression of members of the aryl hydrocarbon
receptor family in uterus and liver of ovariectomized rats was confirmed. These
responses of DBT however were clearly distinct from the response pattern
detectable here for 17β-estradiol. Therefore, DBT exhibited weak, but
significant, estrogenic properties in vivo; however, some of its activities
were independent of the estrogen receptor. Thus, DBT could be an exciting Chinese
herbal decoction for an alternative treatment of hormone replacement therapy
for women in menopause without subsequent estrogenic side effects.
Source: Zierau O,
Zheng KY,
Papke A,
Dong TT,
Tsim KW,
Vollmer G.
Functions of
Danggui Buxue Tang, a Chinese Herbal Decoction Containing Astragali Radix and
Angelicae Sinensis Radix, in Uterus and Liver are Both Estrogen
Receptor-Dependent and -Independent. Evid Based
Complement Alternat Med. 2014;2014:438531.
No comments:
Post a Comment